Application 021494
- Type
- NDA
- Sponsor
- BRAINTREE
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | AXID | NIZATIDINE | SOLUTION;ORAL | 15MG/ML **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons** | Yes | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| N021494-001 | AXID | NIZATIDINE | 15MG/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | SOLUTION / ORAL | RLD | 2004-05-25 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2022-10-28 04:53 UTC | 2022-10 | N021494-001 | AXID | 15MG/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | SOLUTION / ORAL | RLD | 2004-05-25 | f41ea6bd6efb… | |
| 2022-09-29 23:25 UTC | 2022-09 | N021494-001 | AXID | 15MG/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | SOLUTION / ORAL | RLD | 2004-05-25 | e64feba35796… | |
| 2022-07-09 03:26 UTC · 3 captures of this ZIP | 2022-07 | N021494-001 | AXID | 15MG/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | SOLUTION / ORAL | RLD | 2004-05-25 | cb3db0bc1861… | |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | N021494-001 | AXID | 15MG/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | SOLUTION / ORAL | RLD | 2004-05-25 | a50c72e98297… |
Observed Orange Book patent history#
| Captured | Edition | Application-product | Patent | Expiration | Use code | Coverage / status | Submission date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | N021494-001 | 6930119 | 2022-07-17 | Drug product | 5c6f7cd8ea54… | ||
| 2022-04-08 23:34 UTC | 2022-04 | N021494-001 | 6930119 | 2022-07-17 | Drug product | 5d02ea3f76ae… | ||
| 2022-04-04 05:41 UTC | 2022-04 | N021494-001 | 6930119 | 2022-07-17 | Drug product | 4b0b4de00fa7… | ||
| 2019-12-13 00:20 UTC | 2019-12 | N021494-001 | 6930119 | 2022-07-17 | Drug product | 74a2ff9319b5… | ||
| 2022-03-09 01:35 UTC | 2022-03 | N021494-001 | 6930119 | 2022-07-17 | Drug product | bb7c543d1eb4… | ||
| 2021-12-28 21:50 UTC | 2021-12 | N021494-001 | 6930119 | 2022-07-17 | Drug product | 782e0a99824c… | ||
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | N021494-001 | 6930119 | 2022-07-17 | Drug product | 87673890dc5c… | ||
| 2021-03-12 10:30 UTC | 2021-03 | N021494-001 | 6930119 | 2022-07-17 | Drug product | 5aa47cf7b7d7… | ||
| 2020-12-22 03:56 UTC | 2020-12 | N021494-001 | 6930119 | 2022-07-17 | Drug product | 8869cabd3fbd… | ||
| 2020-11-12 02:37 UTC | 2020-11 | N021494-001 | 6930119 | 2022-07-17 | Drug product | c0c555d07b60… | ||
| 2019-12-14 00:12 UTC | 2019-12 | N021494-001 | 6930119 | 2022-07-17 | Drug product | 3f01610625f2… | ||
| 2019-09-15 20:21 UTC | 2019-09 | N021494-001 | 6930119 | 2022-07-17 | Drug product | b00525d2431f… | ||
| 2019-07-19 19:46 UTC | 2019-07 | N021494-001 | 6930119 | 2022-07-17 | Drug product | ea99ee380514… | ||
| 2023-01-26 05:58 UTC | 2023-01 | N021494-001 | 6930119 | 2022-07-17 | Drug product | 3bdfa0b2c4d7… | ||
| 2022-11-12 20:34 UTC · 5 captures of this ZIP | 2022-11 | N021494-001 | 6930119 | 2022-07-17 | Drug product | 3a93d1ddd44b… | ||
| 2022-10-28 04:53 UTC | 2022-10 | N021494-001 | 6930119 | 2022-07-17 | Drug product | f41ea6bd6efb… | ||
| 2022-09-29 23:25 UTC | 2022-09 | N021494-001 | 6930119 | 2022-07-17 | Drug product | e64feba35796… | ||
| 2022-07-09 03:26 UTC · 3 captures of this ZIP | 2022-07 | N021494-001 | 6930119 | 2022-07-17 | Drug product | cb3db0bc1861… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Nizatidine | NIZATIDINE | Epic Pharma, LLC | e9957997-8b85-48a0-9bb3-b878cb223236 | 2025-01-02 | Adverse reactions | NIZATIDINE |
| NIZATIDINE | NIZATIDINE | Amneal Pharmaceuticals LLC | 39e62997-8781-449a-e054-00144ff88e88 | 2024-10-23 | Adverse reactions | NIZATIDINE |
| Nizatidine | NIZATIDINE | Actavis Pharma, Inc. | 367a1004-59c1-4474-a4f6-ce8bf5a1b043 | 2022-06-30 | Adverse reactions | NIZATIDINE |
| Nizatidine | NIZATIDINE | Dr Reddy's Laboratories Limited | faaa7cc4-fda9-d5b8-de2a-71c8744ccb76 | 2018-12-06 | Adverse reactions | NIZATIDINE |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.